Improving participation in HIV vaccine trials through community communication.
Official title: Evaluating a Multilevel Communication Campaign to Increase HIV Vaccine Trial Enrollment
Funded at Fred Hutchinson Cancer Center · NIH-11052511 · Data updated 2026-11-12
This study is working to get more people involved in early HIV vaccine trials by creating a friendly communication campaign that helps clear up misunderstandings and build trust, especially in communities that are most affected by HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | May 19, 2023 |
| Project end | April 1, 2025 |
| Funding year | 2025 |
| Award (this year) | $534,097 |
| NIH project number | 5R01MH132500-03 |
| Project ID | NIH-11052511 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals from marginalized communities, particularly those disproportionately affected by HIV.
✕Less likely to help
Patients who are not part of the targeted communities or those who are not interested in participating in vaccine trials may not benefit from this research.
What this research studies
This research aims to enhance enrollment in early-stage HIV vaccine trials by developing and implementing a multilevel communication campaign. It addresses barriers such as stigma, misinformation, and the perceived urgency of HIV prevention. The approach involves community engagement and partnerships to create trust and awareness, particularly in marginalized communities disproportionately affected by HIV. The campaign will be refined based on community feedback and will include innovative strategies like consumer-driven marketing and virtual town halls.
Why it matters
Potential benefit: If successful, this research could lead to increased participation in HIV vaccine trials, ultimately accelerating the development of effective vaccines.
How similar studies have gone: Previous research has shown success in community engagement strategies for increasing participation in clinical trials, particularly during COVID-19 vaccine trials.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Andrasik, Michele Peake — Fred Hutchinson Cancer Center
- Study coordinator: Andrasik, Michele Peake
Related research
Other NIH-funded projects on the same topics.
-
How brain glia prune neuron fragments in a worm model
Researchers study how brain support cells called glia remove pieces of living neurons in a tiny worm to learn about brain aging and diseases like Alzheimer's.
-
Understanding and Targeting Lineage Plasticity in Prostate Cancer with Genomic-Based Neoadjuvant Therapy
A broad research program at Fred Hutchinson Cancer Center is exploring how aggressive prostate cancers change their cell states in response to therapy and how to block these changes.
-
Personalized cancer drug testing on patient tumor cells
Aiming to test many FDA-approved cancer drugs on a patient’s own tumor cells to identify effective options when standard therapies fail.
-
MOSAAIC: Using health records to track heart disease in Asian American Communities
A big, dedicated effort is testing whether electronic health records can more quickly and accurately track heart and blood vessel problems in Asian American populations.
-
Targeting gut microbes to prevent progression to multiple myeloma
Researchers are testing how specific gut bacteria might trigger immune changes linked to early blood cancer stages and whether targeting these microbes could help prevent progression to multiple myeloma.
-
eDyNAmiC: Understanding extrachromosomal DNA in cancer and how it drives aggressiveness
A cancer research project at Fred Hutchinson Cancer Center is studying abnormal circular DNA pieces (ecDNA) that help cancers grow and resist treatment, with the aim of finding ways to help patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.